PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns

Mass General Brigham researchers found that getting vaccinated on the early side of the recommended window was best for transferring maternal antibodies to the fetus

2024-11-11
(Press-News.org) Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically causes mild, cold-like symptoms in most adults but can be deadly for infants—during weeks 32–36 of pregnancy. New research led by investigators at Mass General Brigham suggests that vaccination earlier in that timeframe, closer to 32 weeks, could provide the best protection for newborns against RSV. The findings are published in the American Journal of Obstetrics & Gynecology.

“Receiving the RSV vaccine in pregnancy is an important way mothers can protect their newborns and infants from RSV, the leading cause of hospitalization in U.S. infants,” said senior author Andrea Edlow, MD MSc, a maternal-fetal medicine specialist in the Department of Obstetrics and Gynecology at Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system. “However, it wasn’t clear whether it was equivalent to vaccinate at any time within the approved window, or whether specific weeks were most optimal. Because the RSV vaccine was ultimately approved for administration during a narrower gestational age window than was originally studied in the large clinical trial, more information was needed about how maternal antibodies travel across the placenta week over week across the approved window.”

 

Edlow and her team’s prior work evaluating prenatal administration of the COVID-19 mRNA vaccines demonstrated that timing of maternal vaccination was associated with altered maternal responses and transplacental antibody transfer to the fetus. To assess whether maternal vaccine timing is also an important consideration for RSV vaccination, the investigators measured RSV antibodies in the umbilical cord at the time of delivery among 124 women who received the RSV vaccine during weeks 32–36 of pregnancy and in the blood of 29 2-month-old infants of these mothers. All study participants were receiving care at Massachusetts General Hospital or Mount Sinai Health System in New York City. Levels of RSV antibodies can predict protection against RSV infection in infants too young to yet receive their own vaccines.

 

The investigators found that maternal RSV vaccination at least 5 weeks prior to delivery led to the most efficient transfer of maternal antibodies across the placenta to the newborn, compared with maternal vaccination at 2-3 or 3-4 weeks prior to delivery.

 

In an additional analysis, RSV antibody levels in maternal and cord blood after RSV vaccination were compared with RSV antibody levels in 20 unvaccinated mothers. Maternal RSV vaccination resulted in significantly higher and longer-lasting maternal and cord RSV antibody levels.

 

“This work provides much-needed data to guide physicians in counseling patients about RSV vaccine timing during pregnancy,” said Edlow. “Our findings suggest that being vaccinated earlier within the approved timeframe allows for the most efficient placental transfer of antibody to the newborn. They also may have implications for when the RSV monoclonal antibody, Nirsevimab, should be administered to newborns. Similar research should be conducted for other vaccines administered during pregnancy.”

 

The investigators noted that additional studies are needed to determine the minimum amount of antibody transfer and/or infant blood antibody levels needed to adequately protect infants against RSV. It will also be important to understand the potential additive protection for infants provided by breastmilk from RSV-vaccinated mothers. This study was designed to measure antibody transfer, but larger studies of infants 2 to 6 months of age will be needed to determine the extent to which this leads to enhanced protection.

 

Authorship: In addition to Edlow, Mass General Brigham authors include Olyvia J. Jasset, Paola Andrea Lopez Zapana, Lydia Shook, Emily Gilbert, Zhaojing Ariel Liu, Rachel V. Yinger, Caroline Bald, Caroline G. Bradford, Alexa H. Silfen, and Lael M. Yonker.

Disclosures: Outside of this work, Edlow serves as a consultant for Mirvie, Inc. and is a consultant for and has received research funding from Merck Pharmaceuticals. Additional disclosures can be found in the paper.

Funding: This work was funded by National Institute of Allergy and Infectious Disease (1U19AI167899, R01AI171980), the National Institute of Child Health and Human Development (5K12HD103096 to L.L.S; NIH/NHLBI: R01HL173059 to L.Y.; MGH ECOR: MGH Research Scholar Award to A.G.E., Claflin Award to L.L.S.; Binational Science Foundation Award number 2019075 to L.K.  None of the funders had any role in the design of the study; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.

Paper cited: Jasset OJ et al. “Enhanced placental antibody transfer efficiency with longer interval between maternal RSV vaccination and birth” AJOG DOI: 10.1016/j.ajog.2024.10.053

For More Information:

Mass General Brigham Prepares for Respiratory Virus Season Tips to Prevent RSV Study shows persistent antibodies in infants after COVID-19 vaccination in pregnancy  

About Mass General Brigham

Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Could lights stop shark attacks

Could lights stop shark attacks
2024-11-11
Surfers could be protected from future shark attacks following new discoveries about how to trick sharks’ visual systems made by Professor Nathan Hart, head of Macquarie University’s Neurobiology Lab, Dr Laura Ryan and colleagues. Hart, Ryan and their co-authors of a new paper in Current Biology titled Counterillumination reduces bites by Great White Sharks say their work “may form the basis of new non-invasive shark deterrent technology to protect human life”. These researchers previously discovered that great whites place a high reliance ...

Alarming increase in alcohol use during pandemic persists

2024-11-11
Embargoed for release until 5:00 p.m. ET on Monday 11 November 2024     @Annalsofim          Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on ...

Pandemic-era increase in alcohol use persists

Pandemic-era increase in alcohol use persists
2024-11-11
LOS ANGELES — Alcohol use increased during the COVID-19 pandemic and remained elevated even after the pandemic ended, according to a large nationally representative Keck Medicine of USC study published today in the Annals of Internal Medicine.   From pre-pandemic (2018) to the height of the pandemic (2020), heavy alcohol use among Americans rose by 20%, and any alcohol use rose by 4%. In 2022, the increases were sustained.   The rise in drinking was seen across all age groups, genders, race, ethnicities and regions of the country, except for Native Americans and Asian Americans. Adults ...

A new milestone in the study of octopus arms

A new milestone in the study of octopus arms
2024-11-11
Mechanical engineering PhD candidate Arman Tekinalp, fellow graduate student Seung Hyun Kim, Professor Prashant Mehta, and Associate Professor Mattia Gazzola, all from the Department of Mechanical Science and Engineering at the University of Illinois Urbana-Champaign, recently published in the Proceedings of the National Academy of Science (PNAS). Their interdisciplinary collaboration also included Assistant Professor Noel Naughton (formerly a Beckman fellow) from the Department of Mechanical Engineering at Virginia Tech alongside researchers from the Department of Molecular and Integrative Physiology at Illinois ...

Fighting microplastics for a cleaner future

2024-11-11
Microplastics, plastics smaller than 5 millimeters, are littered across the world, contributing to global warming, disrupting food chains, and harming ecosystems with toxic chemicals. This is why Dr. Manish Shetty is working to break down plastics before they can get into the environment.   Creating sustainable chemicals and developing better waste management will contribute to better sustainability. This research is part of figuring out how to make green hydrogen available for waste management using catalysts. Shetty’s research uses solvents in low amounts that also act as hydrogen sources to break down a specific class of plastics called ...

Tumor suppressor forms gel-like assemblies to sacrifice cancer cells

Tumor suppressor forms gel-like assemblies to sacrifice cancer cells
2024-11-11
(MEMPHIS, Tenn. – November 11, 2024) There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, including those involving the tumor suppressor protein p53, are widely studied due to their critical role in disease. Through studies of proteins that regulate p53, scientists at St. Jude Children’s Research Hospital have uncoupled a previously unrecognized tumor suppression mechanism. Usually found at low levels in cells, the p14 Alternative Reading Frame protein (p14ARF) is expressed at higher levels under oncogenic stress and activates ...

New research uncovers how Barred Owls interact with urban areas and why it matters

New research uncovers how Barred Owls interact with urban areas and why it matters
2024-11-11
Baton Rouge, November 4, 2024 – Novel research just published in the American Ornithological Society journal, Ornithological Applications, has revealed noteworthy insights into how Barred Owls (Strix varia) interact with urban environments, with implications for both wildlife conservation and urban planning. This study, conducted by a team of biologists from Louisiana State University and other institutions, highlights the connection between owl habitat selection and an urban landscape, underscoring the ...

50 years of survey data confirm African elephant decline

50 years of survey data confirm African elephant decline
2024-11-11
Habitat loss and poaching have driven dramatic declines in African elephants, but it is challenging to measure their numbers and monitor changes across the entire continent. A new study has analyzed 53 years of population survey data and found large-scale declines in most populations of both species of African elephants.  From 1964-2016, forest elephant populations decreased on average by 90%, and savanna elephant populations fell on average by 70%. In combination, populations declined by 77% on average. The study compiled survey data from 475 sites in 37 countries, making it the most comprehensive assessment of African elephants to date.  Declines ...

Swirling polar vortices likely exist on the Sun, new research finds

Swirling polar vortices likely exist on the Sun, new research finds
2024-11-11
EMBARGOED: Until 3 p.m. ET on Monday, Nov. 11, 2024 Contacts:  Laura Snider, NSF NCAR and UCAR Manager of Science Communications lsnider@ucar.edu  303-827-1502 David Hosansky, NSF NCAR and UCAR Manager of Media Relations hosansky@ucar.edu  720-470-2073 Like the Earth, the Sun likely has swirling polar vortices, according to new research led by the U.S. National Science Foundation National Center for Atmospheric Research (NSF NCAR). But unlike on Earth, the formation and evolution of these vortices ...

Protein degradation strategy offers new hope in cancer therapy

Protein degradation strategy offers new hope in cancer therapy
2024-11-11
RIVERSIDE, Calif. -- In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A University of California, Riverside team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development.  The team reports today in the Proceedings of the National Academy of Sciences that it has designed agents that not only bind tightly to Pin1 but are designed to cause its destabilization and cellular ...

LAST 30 PRESS RELEASES:

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

IPK-led research team provides insights into the pangenome of barley

New route to fluorochemicals: fluorspar activated in water under mild conditions

Microbial load can influence disease associations

Three galactic “red monsters” in the early Universe

First ever study finds sexual and gender minority physicians and residents have higher levels of burnout, lower professional fulfillment

Astronomers discover mysterious ‘Red Monster’ galaxies in the early Universe

The secrets of fossil teeth revealed by the synchrotron: a long childhood is the prelude to the evolution of a large brain

Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder

Does AI improve doctors’ diagnoses? Study puts it to the test

Extreme weather accelerates nitrate pollution in groundwater

Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021

Lehigh partners with North Carolina A&T to enhance flood damage mapping with AI and advanced radar

2024 AAAS Kavli Science Journalism Award winners named

Collaborative of prominent academic institutions launches groundbreaking healthcare AI challenge

American Federation for Aging Research announces 2024 AFAR grants for junior faculty

Potential single-dose smallpox and mpox vaccine moves forward

Mass General Brigham Gene and Cell Therapy Institute names Spark Grant recipients

New discovery may lead to more effective treatment for cardiovascular disease

Developing advanced recycling technology to restore spent battery cathode materials

An advance toward inhalable mRNA medications, vaccines

A step toward safer X-rays with new detector technology

[Press-News.org] Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns
Mass General Brigham researchers found that getting vaccinated on the early side of the recommended window was best for transferring maternal antibodies to the fetus